Pyrrolotriazine kinase inhibitors
US7348325B2 · kind B2 · utility
13Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2006 |
| Grant date | Mar 25, 2008 |
| Priority date | — |
| Expiry date | Nov 28, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
In general, the instant invention comprises compounds having Formulae I and II:including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.